Data on Amgens KRASblocking cancer drug are encouraging but also raise new questions httpswww.statnews.com20190908amgenkrashedtk $AMGN WCLC19

Data on Amgen’s KRAS-blocking cancer drug are encouraging, but also raise new questions https://www.statnews.com/2019/09/08/amgen-kras-hed-tk/ … $AMGN #WCLC19

Data on Amgen’s KRAS-blocking cancer drug are encouraging, but also raise new questions https://www.statnews.com/2019/09/08/amgen-kras-hed-tk/ … $AMGN #WCLC19

More From BioPortfolio on "Data on Amgen’s KRAS-blocking cancer drug are encouraging, but also raise new questions https://www.statnews.com/2019/09/08/amgen-kras-hed-tk/ … $AMGN #WCLC19"